tirzepatide for obstructive sleep apnea FDA Approves (Zepbound) as the First Medication Zepbound approved for sleep apnea

Changing GLP-1 medications creates an additional microbiome disruption that probiotic support can help smooth

2 Serum levels of 300 ng/l and above are usually considered normal

Conversely, sites you avoided initially might become viable as your comfort with injection technique improves

GLP-1 weight loss may be combined with body contouring or skin-tightening treatments when appropriate

Obesity, insulin resistance, and type 2 diabetes are all known to increase the risk of dementia, largely due to their role in driving inflammation, vascular damage, and other long-term stressors on the brain

Additionally, the activation of GIP receptors enhances insulin response and complements GLP-1 effects